QJM-An International Journal of Medicine

Papers
(The H4-Index of QJM-An International Journal of Medicine is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The psychological impact of COVID-19 on the mental health in the general population743
The impact of the COVID-19 pandemic on suicide rates638
The impact of the COVID-19 pandemic on the mental health of healthcare professionals136
COVID-19 in nursing homes102
Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study102
Physical and mental health of older people while cocooning during the COVID-19 pandemic99
Post-COVID syndrome and suicide risk98
Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study85
COVID-19 vaccination-associated myelitis72
Secondary attack rate of COVID-19 in household contacts: a systematic review72
Post-COVID-19 pneumonia pulmonary fibrosis66
Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis65
Predictors of UK healthcare worker burnout during the COVID-19 pandemic61
Plasminogen improves lung lesions and hypoxemia in patients with COVID-1955
COVID-19 vaccine-related myositis52
Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?47
The mental health impact of the COVID-19 epidemic on immigrants and racial and ethnic minorities47
COVID-19 and chronic renal disease: clinical characteristics and prognosis38
Psychosocial and coping responses toward 2019 coronavirus diseases (COVID-19): a cross-sectional study within the Chinese general population35
Eosinophil count in severe coronavirus disease 201934
Does vitamin D supplementation reduce COVID-19 severity?: a systematic review34
COVID-19-associated mucormycosis presenting to the Emergency Department—an observational study of 70 patients34
Stroke in a young COVID-19 patient34
Acute myocardial infarction and myocarditis following COVID-19 vaccination34
Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos32
Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination31
Does apolipoprotein E genotype predict COVID-19 severity?30
Psychiatric disorders and suicide in the COVID-19 era30
Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis29
0.047933101654053